Table 2 AP activity and markers of inflammation and lung injury in BALF, corrected for dilution factor
Measure | Patients with ARDS (N = 25) | Patients not having ARDS (N = 58) | p value |
|---|---|---|---|
AP (U/L) | 0.33 (0.14–1.20) | 0.55 (0.21–1.42) | 0.369 |
IL-6 (pg/ml) | 46.57 (7.62–130.77) | 17.55 (4.35–52.29) | 0.128 |
IL-8 (pg/ml) | 274.48 (108.96–3047.86) | 341.91 (126.69–1369.8) | 0.666 |
IL-1β (pg/ml) | 17.91 (0.64–55.44) | 10.54 (2.03–71.70) | 0.603 |
TNF-α (pg/ml) | 1.05 (0.19–7.09) | 1.55 (0.44–5.00) | 0.732 |
MPO (ng/ml) | 30.62 (7.48–127.56) | 98.60 (27.22–266.61) | 0.061 |
SP-D (ng/ml) | 14.45 (5.20–94.34) | 11.35 (3.89–36.46) | 0.308 |